In a rodent study to establish whether neonatal (postnatal day 3–13) leptin treatment can alleviate postnatal obesity and the associated metabolic sequelae that occur in the offspring of undernourished dams, leptin treatment reversed the programmed phenotype [69]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.